nach oben

Erschienen in:

13.05.2012 | Fortbildung

Neurologische Erkrankungen in der Krankheitsendphase unterversorgt

Palliativmedizin in der Praxis

verfasst von: Dr. med. Peter Franz

Erschienen in: NeuroTransmitter | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die Palliativmedizin hat in den letzten Jahren eine umfassende Änderung erfahren. Kam sie in der Vergangenheit, stark geprägt vom Einsatz bei Krebserkrankungen, erst in der Endphase einer todbringenden Krankheit zum Einsatz, hat sich inzwischen die Anwendung palliativer Behandlungskonzepte auf immer mehr Fächer der Medizin und gleichzeitig auch auf längere Behandlungsphasen ausgeweitet.

Abernethy A et al: Effect of oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, radomised-controlled trial. Lancet 379 (2010): 784–793View Article
Allegri RF et al: Neuropsychiatric symptoms as a predictor of caregiver burden in Alzheimer’s disease. Neuropsychiatr. Dis Treat 2 (2006): 105–110PubMed
Aoun S et al: Caregivers of people with neurodegenerative diseases: profile and unmet needs from a population-based survey in South Australia. J Palliat Med 13 (2010): 653–661PubMedView Article
Bausewein C et al: How do patients with primary brain tumours die? Palliat Med 17 (2003): 558–559PubMedView Article
Bausewein C et al: Non-pharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008 Apr. 16;(2):CD005623
Bausewein C et al: Understanding breathlessness: Cross-sectional comparison of symtom burden and palliative care needs in chronic obstructive pulmonary disease and cancer. J Palliat Med 13 (2010): 1109–1118PubMedView Article
Calcagno P et al: Dysphagia in multiple sclerosis — prevalence and prognostic factors. Acta Neurol Scand 105 (2002): 40–43PubMedView Article
Christiakis NA: Extent and determinants of error in doctors’ prognoses in terminally ill patients: prospective cohort studyCommentary: Why do doctors overestimate? Commentary: Prognoses should be based on proved indices not intuition. BMJ 320 (2000): 453–469View Article
Currow DC et al: Once-daily opiods for chronic dyspnea: a dose increment and pharmacovilance study. J Pain Symptom Manage 42 (2011): 388–399PubMedView Article
De Sa JC et al: Symptomatic therapy in multiple sclerosis. A review for a multimodal approach in clinical practice. Ther Adv Neurol Disorders 4 (2011) 139–168View Article
Dreßel, G et al.: Sterben und Tod in Thüringen. Ergebnisse einer sozialwissenschaftlichen Repräsentativbefragung. Jena 2001
Edmonds P et al: Palliative care for people severely affected by multiple sclerosis: evaluation of a novel palliative care service. Multiple Sclerosis 16 (2010): 627–636PubMedView Article
Emanuel EJ et al: Assistence from family members. friends, paid care givers, and volunteers in the care of terminally ill patients. N Engl J Med 341 (1991): 956–963View Article
Figved N et al: Caregiver burden in multiple sclerosis: the impact of neuropsychiatric symptoms. J Neurol Neurosurg Psychiatry 78 (2007): 1097–1102PubMedView Article
Gillick MR: Rethinking the role of tube feeding in patients with advanced dementia. N Engl J Med 342 (2000): 206–210PubMedView Article
Gofton TE et al: A palliative approach to neurological care: A literature review. Can J Neurol Sci 36 (2009): 296–302PubMed
Goy ER et al: Neurological disease at the end of life: caregiver description of Parkinson disease and amyotrophic lateral sclerosis. J Palliat Med 11 (2008): 548–554PubMedView Article
Gysels MH et al: The lived experience of breathlessness and ist implications for care: a qualitative comparison in cancer, COPD, heart failure and MND. BMC Palliative Care 10 (2011):15 http://www.biomedcentral.com/1472-684X/10/15PubMedView Article
Happe S et al: The association between caregiver burden and sleep disturbances in partners of patients with Parkinson’s disease. Age and Aging 31 (2002): 349–354View Article
Higginson IJ et al: Symptom prevalence and severity in people severely affected by multiple sclerosis. J Palliative Care 22 (2006): 158–165
Jennings AL et al: Opiods for the palliation of breathlessness in terminal illness. Cochrane Database Syst Rev 2001: (4): CD002066
Keir ST et al: Stress and long-term survivors of brain cancer. Support Care Cancer 15 (2007): 1423–1428PubMedView Article
Khan S et al: Is nebulized saline a placebo in COPD? BMC Pulm Med 4 (2004): 9PubMedView Article
Lichter I et al: The last 48 hours of life. J Palliat Care 6 (1990): 7–15PubMed
Lipsman N et al: The attitudes of brain cancer patients and their caregivers towards death and dying: a qualitative study. BMC Palliative Care 6 (2007): 7PubMedView Article
Liao S et al: Attitudinal differences in neurodegenerative disorders. J Palliative Med 10 (2007): 430–432View Article
Maninio A et al: Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56 (2005): 1234–1242View Article
Mazzini I et al: Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 242 (1995): 695–698PubMedView Article
Mazzocato C et al: The last days of dying stroke patients referred to a palliative care consult team in an acute hospital. Eur J Neurol 17 (2010): 73–77PubMedView Article
Melching H: Ambulante Versorgungsstrukturen (SAPV und AAPV). Stand 2011. http://www.dgpalliativmedizin.de/images/stories/SAPV-AAPV_Stand_2011_Heiner_Melching.pdf
Miyashita M et al: Care burden and depression in caregivers caring for patients with intractable neurological disease at home in Japan. J Neurol Sci 276 (2009): 148–152PubMedView Article
Morrison RS et al: Cost savings associated with US hospital palliative care consultation programs. Arch Intern Med 168 (2008): 1783–1790PubMedView Article
Oliver D. et al: End of life care in long term neurological conditions. The National Council for Palliative Care 2011.http://www.eapcspeaksrussian.eu/LinkClick.aspx?fileticket=q_VEojsDnkY%3D&tabid=1515
Pace A et al: End of life issues in brain tumor patients. J Neurooncology 91 (2009): 39–43View Article
PAALiativ: http://www.paaliativ.de/index.php/projektbeschreibung
Price A et al: Antidepressants for the treatment of depression in neurological disorders: a systematic review and meta-analysis of randomized controlled trials. J Neurol Neurosurg Psychiatry 82 (2011): 913–914View Article
Ramer S et al: Impaired awarness, behavior disturbance, and caregiver burden in Alzheimer disease. Alzheimer Dis & Associated Dis 16 (2002): 248–253View Article
Reynolds K et al: Dying in nursing home. J Palliative Med 5 (2002): 895–901View Article
Saleem T. et al: Unknown Group of Movement Disorders with Palliative Care Needs — Parkinson’s Plus Syndromes: Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP). EAPC Research Congress, Glasgow. Palliative Medicine 24 (2010):S179
Saposnik G et al: Care and outcome in patients with ischemic stroke with and without preexisting dementia. Neurology 77 (2011): 1664–1673PubMedView Article
Schneider W et al: Wirksamkeit und Qualitätssicherung in der SAPV-Praxis — Eine explorative Begleitstudie. Ergebnisbericht 2011 http://www.philso.uniaugsburg.de/de/lehrstuehle/soziologie/sozio3/interne_medien/schneider/SAPV_Endbericht_FINAL.pdf
Simon ST et al: Benzodiazpines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst Rev 2010 Jan 20; (1): CD007354PubMed
Solano JP et al: A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonry disease and renal disease. J Pain Symptom Manage 31 (2006): 58–69PubMedView Article
Steinhauser KE et al: Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA 284 (2000): 2476–2482PubMedView Article
Stevens Palliative care in stroke: a critical review of the literature. 2007
Tatemichi TK et al: Cognitive impairment after stroke: frquency, patterns, and relationship to functional abilities. J Neuro Neurosurg and Psychiatry 57 (1994): 202–207View Article
Temel JS et al: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363 (2010): 733–742PubMedView Article
Thönnes M et al: Wo sterben Menschen? Zur Frage des Sterbens in Institutionen. Z Gerontol Gerit 44 (2011): 336–339View Article
Wildiers H et al: Atropine, hyoscine butylbromide, or scopolamine are equally effective for the treatment of death rattle in terminal care. J Pain Symptom Manage 38 (2009):124–133PubMedView Article
Kalia LV et al. Severity of chronic pain and ist relationship to quality of life in multiple sclerosis. Mutl Scler 11 (2005): 322–327View Article
Kehyia E et al: Differences in pain medication use in stroke patients with aphasia and without aphasia. Stroke 28 (1997): 1867–1870View Article
Kong KH et al: Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehabil 85 (2004): 35–40PubMedView Article
Kümpfel T et al: Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists. Palliat Med 21 (2007): 109–114PubMedView Article
O’Connor AB et al: Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 137 (2008): 96–111PubMedView Article
Schrag A et al: Caregiver-burden in parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 12 (2006): 35–41PubMedView Article
Yourman LC et al: Prognostic indices for older adults. JAMA 307 (2012): 182–192PubMedView Article
Fritz Beske Institut für Gesundheits-System-Forschung Kiel. Pressekonferenz 24.02.2011 n Berlin. Wer wird in Zukunft pflegen und zahlen? http://www.igsf.de/PM_kurz_119.pdf

Titel: Neurologische Erkrankungen in der Krankheitsendphase unterversorgt
Palliativmedizin in der Praxis
verfasst von: Dr. med. Peter Franz
Publikationsdatum: 13.05.2012
Verlag: Urban and Vogel
Erschienen in: NeuroTransmitter / Ausgabe 5/2012
Print ISSN: 1436-123X
Elektronische ISSN: 2196-6397
DOI: https://doi.org/10.1007/s15016-012-0158-8

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

16.04.2024 | Maligne primäre ZNS-Tumoren | Nachrichten

Manche Gestagene können das Risiko für Meningeome erhöhen

15.04.2024 | Parkinson-Krankheit | Nachrichten

Parkinson: Größere Studie bestätigt Genauigkeit von Hauttest

11.04.2024 | Aphasie | Nachrichten

Simple Kortisontherapie stoppt primär progrediente Aphasie

09.04.2024 | Hyperhidrose | Nachrichten

Impostor-Syndrom häufig bei Hyperhidrose zu finden

weitere anzeigen

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2012

Zytostatika und ihre Beeinflussung durch Psychopharmaka

Moderne Methoden der Gliomresektion

Ade

Honorargerechtigkeit liegt am Herzen

Familiäre Amyloid-Polyneuropathie: Die Neurodegeneration aufhalten

Schmerzhafte diabetische PNP